Skip to content

mRNA Design and Optimization with Deep Knowledge-Infused Approach

May 2025 · 7 citations · ⚡ 1 influential · 40 references
Biology Computer Science

TL;DR

RNop represents a shift in mRNA optimization methodology: by infusing explicit and interpretable knowledge, the"black-box"mRNA design can be transformed into a predictable, explainable engineering problem.

Abstract

The mRNA optimization is essential for mRNA vaccines, therapies, and industrial protein production. Based on current explorations, an ideal optimization approach should simultaneously (i) prevent unintended amino-acid changes, (ii) optimize multiple, biologically relevant objectives, and (iii) retain computational efficiency. However, existing methods are forced to trade off between these perspectives, forming an"impossible triangle."We present RNop, a knowledge-infused Transformer that integrates mechanism-aligned losses to address this problem. By encoding biological prior knowledge in losses, RNop makes knowledge infusion explicit and controllable across optimization focus. Trained on over 6 million sequences, in silico analyses show RNop resolves the"impossible triangle"of mRNA optimization with absolute sequence fidelity, significantly improved biological metrics, and high throughput. In in vitro validation, it can deliver up to 2.28-fold expression gain. Ablation studies reveal how each prior contributes to targeted improvements, yielding mechanism-level interpretability. RNop represents a shift in mRNA optimization methodology: by infusing explicit and interpretable knowledge, the"black-box"mRNA design can be transformed into a predictable, explainable engineering problem. RNop is designed as an extensible platform: additional biological priors can be incorporated as modular, mechanism-aligned loss functions, enabling future development and adaptation to related sequence design problems.

View source

Similar papers

#generative ai Review Open access Sep 2026

Prospecting the protein design landscape.

This review outlines the current landscape of deep learning-driven protein design pipelines, discusses tailored applications in peptide, small molecule, binder, vaccine, and antibody design, and argues that the integration of ensemble-based methods represents a promising avenue for improving design success rates.

Jakob R. Riccabona, Katharina T. Stonig, J. Meiler et al. · 0 citations
Aug 2026

Structure- and deep learning-guided engineering of a size-minimized CRISPR/Cas.

UCRISPRa achieved selective activation of olfr544 among more than a thousand homologous olfactory receptor genes in skeletal muscle cells, leading to enhanced mitochondrial biogenesis and broad potential for precise gene regulation and functional studies of complex macromolecular systems.

Smith Le, T. Thach · 0 citations
Open access Sep 2026

OmniSyn unifies target-aware molecular generation and optimization within a synthesis-native LLM framework across the human proteome

Designing target-specific bioactive molecules with actionable synthesis routes for the human proteome holds enormous potential for expanding therapeutic discovery, but remains a challenge. Existing target-aware generative models often depend on protein structures and generate molecules before assessing synthetic feasib...

Zheng Qin, Yu-Zhang Li, Yue-Qing Zhang et al. · 0 citations
Preprint Aug 2026

Optimizing RNA yield using deep neural networks coupled to massively parallel screening

Messenger RNA (mRNA)-based therapeutics have emerged as a powerful platform for vaccines, protein replacement therapies, and cancer immunotherapy. A critical bottleneck in mRNA development is manufacturing large quantities of RNA economically, as measured by RNA yield emerging from an in vitro transcription (IVT) react...

Ding-Hai Zheng, Justin Hong, Jun Wang et al. · 0 citations
Review Open access Sep 2026

Artificial intelligence–assisted lead optimization in drug discovery: bridging computational advances and translational challenges

It is concluded that future progress will depend less on increasingly sophisticated algorithms than on trustworthy AI systems that improve scientific decision-making within iterative lead optimization workflows and ultimately enhance translational success in drug discovery.

Fatma A. Mohamed, A. M. K. El-sagheir · 1 citation
Preprint Aug 2026

Synthesizing like a chemist: an iterative, feedback-driven loop for materials discovery

Most computationally predicted materials are never synthesized because conventional synthesis optimization is slow, expertise-dependent, and iterative. Here we present a closed-loop framework that automates this expert workflow by placing human tacit knowledge in the loop through a large language model (LLM) that disti...

Fang Sheng, S. Torrisi, Amanda A. Volk et al. · 0 citations

Related blog posts

MIT News · Artificial Intelligence Sep 29, 2026

Who we become when we talk to machines

Professor Sherry Turkle’s new book, “Artificial Intimacy,” offers a withering critique of chatbots and the antisocial dynamics she believes they encourage.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.